Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis

Lindsay, 2005, Managing recurrent urinary tract infections in women, Womens Health, 1, 39

Naber KG (Chairman), Bishop MC, Bjerklund-Johansen TE, Botto H, Çek M, Grabe M, et al. Guidelines on the management of urinary and male genital tract infections. European Association of Urology; 2006. p. 7–8, Appendices 12.1 [Criteria for the diagnosis of a UTI], p. 109.

Fihn, 2003, Acute uncomplicated urinary tract infection in women, N Engl J Med, 349, 259, 10.1056/NEJMcp030027

Boyko, 2005, Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women, Am J Epidemiol, 161, 557, 10.1093/oxfordjournals.aje.a000181

Raz, 2000, Recurrent urinary tract infections in postmenopausal women, Clin Infect Dis, 30, 152, 10.1086/313596

Ishitoya, 2002, Non-secretor status is associated with female acute uncomplicated pyelonephritis, BJU Int, 89, 851, 10.1046/j.1464-410X.2002.02782.x

Schaeffer, 2001, Host pathogenesis in urinary tract infections, Int J Antimicrob Agents, 17, 245, 10.1016/S0924-8579(01)00302-8

Hidalgo-Tenorio, 2004, Urinary tract infections and lupus erythematosus, Ann Rheum Dis, 63, 431, 10.1136/ard.2003.006346

Hughes, 2004, Genetic risk factors for infection in patients with early rheumatoid arthritis, Genes Immun, 5, 641, 10.1038/sj.gene.6364137

Schmidhammer, 2002, An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells, Urology, 60, 521, 10.1016/S0090-4295(02)01767-3

Boruchov, 2005, Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions, J Clin Invest, 115, 2914, 10.1172/JCI24772

David J, Terhorst C. Organs and cells of the immune system. In: Scientific American Medicine; Ch. 6. Immunology. WebMD Corp.; 1999.

Jerome, 2004, The danger within, N Engl J Med, 350, 411, 10.1056/NEJMcibr032455

Anders, 2005, Toll-like receptors recognize uropathogenic Escherichia coli and trigger inflammation in the urinary tract, Nephrol Dial Transplant, 20, 1529, 10.1093/ndt/gfh922

Yahr, 2006, A critical new pathway for toxin secretion?, N Engl J Med, 355, 1171, 10.1056/NEJMcibr063931

Kerschbaum, 1995, Lymphoid tissue in the kidney of the musk shrew, Suncus murinus, Tissue Cell, 27, 421, 10.1016/S0040-8166(95)80062-X

Thilagarajah, 1998, Quantitative histopathology can aid diagnosis in painful bladder syndrome, J Clin Pathol, 51, 211, 10.1136/jcp.51.3.211

Franz, 1999, Common errors in diagnosis and management of urinary tract infection. I. Pathophysiology and diagnostic techniques, Nephrol Dial Transplant, 14, 2746, 10.1093/ndt/14.11.2746

Kunin, 2002, The antimicrobial defense mechanism of the female urethra: a reassessment, J Urol, 168, 413, 10.1016/S0022-5347(05)64649-6

Pudney, 1995, Immunobiology of the human penile urethra, Am J Pathol, 147, 155

Bauer, 2002, Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies, Int J Antimicrob Agents, 19, 451, 10.1016/S0924-8579(02)00106-1

Alderson P, Green S, Higgins JPT, editors. Cochrane Handbook for Systematic Reviews of Interventions [version 4.2.2, updated March 2004]. In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, Ltd.; 2004. http://www.cochrane.org/resources/handbook/index.htm [accessed 8 September 2008].

Bax, 2006, Development and validation of MIX: comprehensive free software for meta-analysis of causal research data, BMC Med Res Methodol, 6, 50, 10.1186/1471-2288-6-50

Hachen, 1990, Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double-blind, placebo-controlled trial, J Urol, 143, 759, 10.1016/S0022-5347(17)40084-X

Frey, 1986, Treatment of recurrent urinary tract infections: efficacy of an orally administered biological response modifier, Urol Int, 41, 444, 10.1159/000281253

Bauer, 2005, A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections, Eur Urol, 47, 542, 10.1016/j.eururo.2004.12.009

Pisani, 2006, BioDrugs, 20, 141, 10.2165/00063030-200620030-00001

Magasi, 1994, Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial, Eur Urol, 26, 137, 10.1159/000475363

Schulman, 1993, Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study, J Urol, 150, 917, 10.1016/S0022-5347(17)35648-3

Tammen, 1990, Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection, Br J Urol, 65, 6, 10.1111/j.1464-410X.1990.tb14649.x

Scottish Intercollegiate Guidelines Network. Management of suspected bacterial urinary tract infection in adults. A national clinical guideline. July 2006.

Pam, 2002, Vaginal vaccine for recurrent urinary-tract infections, Lancet Infect Dis, 2, 68, 10.1016/S1473-3099(02)00200-1

Überempfindlichkeitsreaktionen auf ‘Impfstoff’ STROVAC [Hypersensitivity reactions to ‘vaccine’ STROVAC]. Arznei-Telegram 2007; 38(2):31.

Uehling, 2001, Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial, J Infect Dis, 183, S81, 10.1086/318839

Uehling, 1997, Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial, J Urol, 157, 2049, 10.1016/S0022-5347(01)64671-8

Uehling, 2003, Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections, J Urol, 170, 867, 10.1097/01.ju.0000075094.54767.6e

Hopkins, 2007, Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial, J Urol, 177, 1349, 10.1016/j.juro.2006.11.093

Hooton, 1997, Diagnosis and treatment of uncomplicated urinary tract infection, Infect Dis Clin North Am, 11, 551, 10.1016/S0891-5520(05)70373-1

Kahlmeter, 2000, The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens—interim report, J Antimicrob Chemother, 46, 15, 10.1093/jac/46.suppl_1.15

Gupta, 2001, Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis, Clin Infect Dis, 33, 89, 10.1086/320880

Manges, 2001, Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group, N Engl J Med, 345, 1007, 10.1056/NEJMoa011265

Albert, 2004, Antibiotics for preventing recurrent urinary tract infection in non-pregnant women, Cochrane Database Syst Rev, 10.1002/14651858.CD001209.pub2

Gradwohl SE (Team Leader); University of Michigan Health System (Agency for Healthcare Research and Quality (AHRQ)). Urinary tract infection. Ann Arbor, MI: University of Michigan Health System; 2005. http://www.guidelines.gov/summary/summary.aspx?view_id=1&doc_id=7407 [accessed 3 September 2008].

Ball, 1999, Comparative tolerability of the newer fluoroquinolone antibacterials, Drug Saf, 21, 407, 10.2165/00002018-199921050-00005

Sheehan, 2000, Nitrofurantoin-induced lung disease: two cases demonstrating resolution of apparently irreversible CT abnormalities, J Comput Assist Tomogr, 24, 259, 10.1097/00004728-200003000-00013

Howe, 1996, Cotrimoxazole: rationale for re-examining its indications for use, Drug Saf, 14, 213, 10.2165/00002018-199614040-00001

Norinder, 2006, Microflora changes with norfloxacin and pivmecillinam in women with recurrent urinary tract infection, Antimicrob Agents Chemother, 50, 1528, 10.1128/AAC.50.4.1528-1530.2006

Edlund, 2000, Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections, J Antimicrob Chemother, 46, 41, 10.1093/jac/46.suppl_1.41

Langermann, 2000, Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli, J Infect Dis, 181, 774, 10.1086/315258

Pellegrino, 2003, Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections, FEMS Immunol Med Microbiol, 36, 103, 10.1016/S0928-8244(03)00103-2

Li, 2004, Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis, Infect Immun, 72, 66, 10.1128/IAI.72.1.66-75.2004